Skip to main content

Home
Specialties
Resources
CME

Search Videos and More

search

Channel Categories

Breast Cancer (6)
Cancer Screening and Survivorship (4)
Cell Therapy (20)
Clinical Trials (9)
COVID-19 (2)
Gastrointestinal Cancer (4)
Genitourinary Cancer (4)
Gynecologic Oncology (4)
Head and Neck Cancer (4)
Hematologic Oncology (13)
Immunotherapy (43)
Neuro-Oncology (3)
Pediatric Hematology/Oncology (3)
Primary Care (4)
Radiation Oncology (4)
Skin Cancer (4)
Thoracic Cancer (9)
Young Adult Malignancies (2)

Types

News (32)
Video Asset (11)

Showing 1 - 12 of 43 results

Previous| 1 | 2 | 3 ...4 |Next

Immune Checkpoint Inhibitors ‘High-Risk Yet Promising’ for Cancer Patients Who Undergo Organ Transplant

Immune Checkpoint Inhibitors ‘High-Risk Yet Promising’ for Cancer Patients Who Undergo Organ Transplant

Roswell Park Quick Talks: Breast Cancer and ADCs, Risk of Second HPV-Related Cancer, Cognitive Function and ICIs

Roswell Park Quick Talks: Breast Cancer and ADCs, Risk of Second HPV-Related Cancer, Cognitive Function and ICIs

ASCO 2025 Highlights: Menin Inhibitor for Acute Myeloid Leukemia; Organ Transplant and Checkpoint Inhibitors

ASCO 2025 Highlights: Menin Inhibitor for Acute Myeloid Leukemia; Organ Transplant and Checkpoint Inhibitors

Roswell Park is Hiring!

Roswell Park is Hiring!

Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung Cancer

Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung Cancer

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

$Clinical Trial Utilizes Novel CAR Target for Relapsed/Refractory Multiple Myeloma$ News

Clinical Trial Utilizes Novel CAR Target for Relapsed/Refractory Multiple Myeloma

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer

Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Showing 1 - 12 of 43 results

Previous| 1 | 2 | 3 ...4 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer